CENGİZ SEVAL, G. Et Al. 2022. Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable. 19th International Myeloma Society Annual Meeting .

CENGİZ SEVAL, G., KUZU, I., Yüksel, S., YILMAZ, H., Yavuz, G., KAYGUSUZ, G., ... DALVA, K.(2022). Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable . 19th International Myeloma Society Annual Meeting

CENGİZ SEVAL, GÜLDANE Et Al. "Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable," 19th International Myeloma Society Annual Meeting, 2022

CENGİZ SEVAL, GÜLDANE C. Et Al. "Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable." 19th International Myeloma Society Annual Meeting , 2022

CENGİZ SEVAL, G. Et Al. (2022) . "Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable." 19th International Myeloma Society Annual Meeting .

@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable}, congress name={19th International Myeloma Society Annual Meeting}, city={}, country={}, year={2022}}